Your browser doesn't support javascript.
Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India.
Nath, Ravindra; Gupta, Neeraj Kumar; Jaswal, Amandeep; Gupta, Sparsh; Kaur, Navjot; Kohli, Santvana; Saxena, Anirudh; Ish, Pranav; Kumar, Rohit; Tiwari, Poornima; Kumar, Mukesh; Kishore, Jugal; Yadav, Geeta; Marwein, Fellisha; Gupta, Nitesh.
  • Nath R; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. rnath24.9@gmail.com.
  • Gupta NK; Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. drgupta.nk@gmail.com.
  • Jaswal A; Department of Anaesthesiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. amandeep.jaswal@gmail.com.
  • Gupta S; Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. Healing_sparsh@yahoo.co.in.
  • Kaur N; Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. drnavjotpharma@gmail.com.
  • Kohli S; Department of Anaesthesiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. dr.santvana.kohli@gmail.com.
  • Saxena A; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. 27.anirudh@gmail.com.
  • Ish P; Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. pranavish2512@gmail.com.
  • Kumar R; Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. dr.rohitkumar@mail.com.
  • Tiwari P; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. sheeloopoonam@yahoo.com.
  • Kumar M; Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. muku90delhi@gmail.com.
  • Kishore J; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. drjugalkishore@gmail.com.
  • Yadav G; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. yadavgeeta07@gmail.com.
  • Marwein F; Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. fely.marz@yahoo.com.
  • Gupta N; Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi. niteshgupta2107@gmail.com.
Monaldi Arch Chest Dis ; 92(2)2021 Oct 11.
Article in English | MEDLINE | ID: covidwho-1463905
ABSTRACT
The similarities and differences between the mortality patterns of the two waves in India remain largely unknown. This was a retrospective study of medical records conducted in the COVID data center of our hospital This study analyzed data of patients who died in the month of August, 2020 to October 2020 (one month before and after the peak of first wave i.e., 16th September, 2020) and April 2021 to June 2021 (one month before and after the peak of second wave i.e., 6th May, 2021), corresponding to an equal part of the pandemic during first (2020) and second (2021) wave. Out of 1893 patients in the study, 764 patients were admitted during the first wave and 1129 patients during the second wave of pandemic. In total, 420 patients died during the entire study period. Of those, 147 (35%) deaths occurred during the first wave and 273 (65%) during the second wave, reflecting a case fatality rate (CFR) of 19.2% during the first wave and a CFR of 24.18%. There were no significant differences in the age group, gender, presenting complaints, duration of stay and comorbidities. However, the deceased COVID-19 patients had an increase in case fatality rate, average duration of symptoms from onset to hospital admission (DOSHA) and a major shift from MODS to ARDS being the cause of death during the second wave of pandemic. This study demonstrates increased CFR, average DOSHA and a paradigm shift to ARDS as cause of mortality during the second peak of the pandemic. It is necessary to remain vigilant of newer COVID-19 variants of concern, follow COVID-19 appropriate behaviors and keep emphasizing on care of high-risk groups including patients with comorbidities and elderly population to prevent mortality.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Aged / Humans Country/Region as subject: Asia Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Aged / Humans Country/Region as subject: Asia Language: English Year: 2021 Document Type: Article